Sanofis Diabetes Drug Gets EU Nod

Sanofis Diabetes Drug Gets EU Nod
Recently, Sanofi (SNY – Analyst Report) received encouraging news with the European Commission (EC) approving its diabetes candidate, Lyxumia (lixisenatide). The EC cleared Lyxumia for glycemic control in patients, above 18 years of age, suffering from …

Full News here – Read more on Zacks.com

Leave a Reply